Cargando…
Sulfonylurea-Induced Hypoglycemia in a Patient With Cirrhosis
Type 2 diabetes mellitus is highly prevalent among patients with cirrhosis. The pharmacological management of this disease in patients with chronic liver disease remains controversial, however. Insulin secretagogues such as sulfonylureas are associated with a high risk of hypoglycemia among diabetic...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346303/ https://www.ncbi.nlm.nih.gov/pubmed/32656029 http://dx.doi.org/10.7759/cureus.8513 |